Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
Controlling Cancer Without SurgeryImmunotherapy can induce a complete response in some people with mismatch repair-deficient cancers with solid tumors.
by Thomas Celona
Alleviating Skin Side Effects in Colorectal CancerA clinical trial finds a topical gel can decrease acneiform rash and improve quality of life in people being treated for colorectal cancer.
by Thomas Celona
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
The Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
